Tin tức & Cập nhật

Survodutide promotes weight loss in adults with obesity

In patients with obesity but without diabetes, treatment with survodutide results in substantial reductions in body weight compared with placebo, according to the phase III SYNCHRONIZE-1 trial.

GLP-1RAs up risk for ischaemic optic neuropathy in T2D patients

The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) results in an increased risk for ischaemic optic neuropathy (ION) at 18 months when compared with the use of sodium‒glucose cotransporter-2 inhibitors (SGLT2is) and dipeptidyl peptidase-4 inhibitors (DPP4is), reports a study.

Older age, obesity, T2D linked to hypertension-mediated organ damage

Factors including older age, obesity, and type 2 diabetes (T2D) characterize individuals with subclinical hypertension-mediated organ damage (HMOD) in The Maastricht Study.

Dextrose gel to prevent transitional neonatal hypoglycaemia may do more harm than good

Administering a single dose of dextrose gel as prophylaxis against transitional neonatal hypoglycaemia does not help with the risk of neurocognitive impairment at early school age and even appears to have adverse effects on psychological well-being, according to a study.

Patients with MASLD face heightened diabetes risk

Metabolic dysfunction-associated steatotic liver disease (MASLD) carries an increased risk of type 2 diabetes (T2D), with the risk increase disproportionately higher for individuals with earlier-onset MASLD, as shown in a study.

Cagrilintide–semaglutide improves glycaemic control in early-stage diabetes

Treatment with the combination of cagrilintide plus semaglutide is safe and efficacious for lowering glycaemic levels in individuals with early-stage type 2 diabetes inadequately controlled with diet and exercise, as shown in the phase IIIa REIMAGINE 1 trial.

SGLT2 inhibitor use helps reduce cardiovascular, renal deaths

Patients with diabetes mellitus, heart failure, or chronic kidney disease treated with sodium glucose co-transporter-2 inhibitors (SGLT2i) have a reduced risk of mortality from cardiovascular and renal causes, according to a study.

Semaglutide associated with reduced ICH risk in LVO treated with reperfusion therapy

Co-treatment with yoga plus camelina sativa powder improves outcomes in women with T2D

In women with type 2 diabetes (T2D), performing yoga in addition to supplementation with camelina sativa powder (CSP) delivers improvements in glycaemic indices, oxidative stress, and inflammatory markers, according to a study.